T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.

Cunte Chen,Ling Huang,Sichu Liu,Xinmiao Jiang,Feili Chen,Xiaojuan Wei,Hanguo Guo,Xiangbo Zeng,Chengwu Zeng,Grzegorz K Przybylski,Wenyu Li,Yangqiu Li

Asia-Pacific journal of clinical oncology（2023）

引用 0|浏览14

暂无评分

摘要

BCL11B mutations were associated with favorable clinical outcome for TCL patients; it might be considered as a novel biomarker for TCL prognostic stratification.

查看译文

关键词

BCL11B, biomarker, mutation, prognosis, T-cell lymphoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要